Literature DB >> 9054474

Serum leptin concentrations in human immunodeficiency virus-infected men with low adiposity.

K E Yarasheski1, J J Zachwieja, M M Horgan, W G Powderly, J V Santiago, M Landt.   

Abstract

The product of the obese gene (ob) is the protein leptin, which is synthesized in and secreted from adipocytes. Fasting serum leptin concentrations are closely related to body fat content and are higher in obese than in normal-weight individuals. Leptin may contribute to body weight regulation. Overproduction of leptin in certain pathologic conditions such as acquired immunodeficiency syndrome (AIDS) might in principle contribute to the low body fat content associated with body wasting. We measured fasting serum leptin levels by radioimmunoassay in individuals infected with the human immunodeficiency virus (HIV) and in a group of healthy lean men to determine whether HIV infection increases leptin levels. Thirteen HIV-infected men aged 26 to 50 years with a body mass index (BMI) of 15 to 26 kg/m2 and 4 to 24 kg body fat (7% to 29% body fat) had serum leptin levels (3.4 +/- 1.6 ng/mL) that were not elevated compared with the levels in 17 healthy men (4.0 +/- 1.4 ng/mL) matched for age (23 to 47 years), BMI (18 to 26 kg/m2), and body fat (5 to 21 kg; 9% to 28%). In both groups of men, serum leptin concentrations were correlated with percent body fat and body fat content (P < .001), and these relationships were not different between the two groups. In both groups, leptin concentrations were not correlated with lean body mass (P > or = .24). Energy intake in the HIV-infected men, assessed from 3-day intake records, was within the normal range. These findings extend the hypothesis that circulating leptin concentrations directly reflect adipose tissue mass, even in HIV-infected men with low body fat content. These findings do not support the hypothesis that HIV infection is associated with high circulating leptin concentrations, and suggest that low leptin levels do not stimulate food intake in HIV-infected individuals.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9054474      PMCID: PMC3176667          DOI: 10.1016/s0026-0495(97)90258-4

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  12 in total

1.  Body composition studies in patients with the acquired immunodeficiency syndrome.

Authors:  D P Kotler; J Wang; R N Pierson
Journal:  Am J Clin Nutr       Date:  1985-12       Impact factor: 7.045

2.  Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters.

Authors:  C Grunfeld; C Zhao; J Fuller; A Pollack; A Moser; J Friedman; K R Feingold
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

3.  Radioimmunoassay of leptin in human plasma.

Authors:  Z Ma; R L Gingerich; J V Santiago; S Klein; C H Smith; M Landt
Journal:  Clin Chem       Date:  1996-06       Impact factor: 8.327

4.  Age-related differences in body composition by hydrodensitometry and dual-energy X-ray absorptiometry.

Authors:  D B Snead; S J Birge; W M Kohrt
Journal:  J Appl Physiol (1985)       Date:  1993-02

5.  Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity.

Authors:  R V Considine; E L Considine; C J Williams; M R Nyce; S A Magosin; T L Bauer; E L Rosato; J Colberg; J F Caro
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

6.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans.

Authors:  R V Considine; M K Sinha; M L Heiman; A Kriauciunas; T W Stephens; M R Nyce; J P Ohannesian; C C Marco; L J McKee; T L Bauer
Journal:  N Engl J Med       Date:  1996-02-01       Impact factor: 91.245

7.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

8.  Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissue.

Authors:  H Masuzaki; Y Ogawa; N Isse; N Satoh; T Okazaki; M Shigemoto; K Mori; N Tamura; K Hosoda; Y Yoshimasa
Journal:  Diabetes       Date:  1995-07       Impact factor: 9.461

9.  Effects of the obese gene product on body weight regulation in ob/ob mice.

Authors:  M A Pelleymounter; M J Cullen; M B Baker; R Hecht; D Winters; T Boone; F Collins
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

10.  Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks.

Authors:  L A Campfield; F J Smith; Y Guisez; R Devos; P Burn
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

View more
  10 in total

1.  Plasma leptin concentration increases early during highly active antiretroviral therapy for acquired immunodeficiency syndrome, independent of body weight.

Authors:  M L Fox; M K Sastry; D M Parenti; G L Simon
Journal:  J Endocrinol Invest       Date:  2005-03       Impact factor: 4.256

2.  Leptin and Adiponectin in the HIV Associated Metabolic Syndrome: Physiologic and Therapeutic Implications.

Authors:  Sotirios Tsiodras; Christos Mantzoros
Journal:  Am J Infect Dis       Date:  2006

3.  Leptin and Inflammation.

Authors:  Noriko Iikuni; Queenie Lai Kwan Lam; Liwei Lu; Giuseppe Matarese; Antonio La Cava
Journal:  Curr Immunol Rev       Date:  2008-05-01

Review 4.  Leptin in inflammation and autoimmunity.

Authors:  Antonio La Cava
Journal:  Cytokine       Date:  2017-10       Impact factor: 3.861

Review 5.  Leptin in immuno-rheumatological diseases.

Authors:  Marta Vadacca; Domenico P E Margiotta; Luca Navarini; Antonella Afeltra
Journal:  Cell Mol Immunol       Date:  2011-03-14       Impact factor: 11.530

6.  Association between HIV replication and serum leptin levels: an observational study of a cohort of HIV-1-infected South African women.

Authors:  Livio Azzoni; Nigel J Crowther; Cynthia Firnhaber; Andrea S Foulkes; Xiangfan Yin; Deborah Glencross; Robert Gross; Mitch D Kaplan; Emmanouil Papasavvas; Doreen Schulze; Wendy Stevens; Tessa van der Merwe; Rita Waisberg; Ian Sanne; Luis J Montaner
Journal:  J Int AIDS Soc       Date:  2010-09-07       Impact factor: 5.396

Review 7.  The role of leptin in innate and adaptive immune responses.

Authors:  Eiva Bernotiene; Gaby Palmer; Cem Gabay
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

Review 8.  Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals.

Authors:  Hyun-Seuk Moon; Maria Dalamaga; Sang-Yong Kim; Stergios A Polyzos; Ole-Petter Hamnvik; Faidon Magkos; Jason Paruthi; Christos S Mantzoros
Journal:  Endocr Rev       Date:  2013-03-08       Impact factor: 19.871

9.  Association of body mass index with immune recovery, virological failure and cardiovascular disease risk among people living with HIV.

Authors:  W M Han; A Jiamsakul; J Jantarapakde; E Yunihastuti; J Y Choi; R Ditangco; R Chaiwarith; L P Sun; S Khusuwan; T P Merati; C D Do; I Azwa; M-P Lee; K Van Nguyen; Y-J Chan; S Kiertiburanakul; O T Ng; J Tanuma; S Pujari; F Zhang; Y M Gani; S Sangle; J Ross; N Kumarasamy
Journal:  HIV Med       Date:  2020-11-17       Impact factor: 3.180

Review 10.  Role of cytokines in AIDS wasting.

Authors:  H R Chang; A G Dulloo; B R Bistrian
Journal:  Nutrition       Date:  1998 Nov-Dec       Impact factor: 4.008

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.